BROOKSNSEBrooks Laboratories Limited· PharmaceuticalsHighNeutral
Announced Fri, 19 Jun · 21:43 IST

Brooks Labs to sell 16.33% stake in Brooks Steriscience for Rs 106.33 cr

Core Business DivestedStrategic Transactions View source PDF

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+7.9%1-day move
₹68.10
prior close
₹70.01
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+7.9+13.1+7.5+3.5+1.1+11.5+2.9-3.1
Up moveDown movePending
AI summary

Brooks Labs board on 19 Jun 2026 approved sale of 51,220 shares (16.33% stake) in Brooks Steriscience to Steriscience Specialties at Rs 20,760 per share, about Rs 106.33 crore total. Post-sale, Brooks Labs holding drops from 49% to 32.67%. Proceeds will fund expansion, capacity enhancement, and general corporate needs. Not a related party deal.

Likely market impact

Cash infusion of about Rs 106.33 crore for growth. Brooks Labs retains 32.67% stake. Partial monetization, not a full exit.